April 4, 2018 / 3:53 PM / in 6 months

BRIEF-Inventiva Announces U.S. Phase II Investigator-Initiated Study With Lanifibranor

April 4 (Reuters) - Inventiva SA:

* INVENTIVA ANNOUNCES A U.S. PHASE II INVESTIGATOR-INITIATED STUDY WITH LANIFIBRANOR ON NON ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH TYPE 2 DIABETES

* DR. KENNETH CUSI OF UNIVERSITY OF FLORIDA TO BE PRINCIPAL INVESTIGATOR

* TRIAL IN 64 PATIENTS TO BEGIN AFTER FDA HAS APPROVED LANIFIBRANOR IND Source text for Eikon: Further company coverage: (Gdynia Newsroom:)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below